Unknown

Dataset Information

0

Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients.


ABSTRACT: Cancer patient classification using predictive biomarkers for anti-cancer drug responses is essential for improving therapeutic outcomes. However, current machine-learning-based predictions of drug response often fail to identify robust translational biomarkers from preclinical models. Here, we present a machine-learning framework to identify robust drug biomarkers by taking advantage of network-based analyses using pharmacogenomic data derived from three-dimensional organoid culture models. The biomarkers identified by our approach accurately predict the drug responses of 114 colorectal cancer patients treated with 5-fluorouracil and 77 bladder cancer patients treated with cisplatin. We further confirm our biomarkers using external transcriptomic datasets of drug-sensitive and -resistant isogenic cancer cell lines. Finally, concordance analysis between the transcriptomic biomarkers and independent somatic mutation-based biomarkers further validate our method. This work presents a method to predict cancer patient drug responses using pharmacogenomic data derived from organoid models by combining the application of gene modules and network-based approaches.

SUBMITTER: Kong J 

PROVIDER: S-EPMC7599252 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients.

Kong JungHo J   Lee Heetak H   Kim Donghyo D   Han Seong Kyu SK   Ha Doyeon D   Shin Kunyoo K   Kim Sanguk S  

Nature communications 20201030 1


Cancer patient classification using predictive biomarkers for anti-cancer drug responses is essential for improving therapeutic outcomes. However, current machine-learning-based predictions of drug response often fail to identify robust translational biomarkers from preclinical models. Here, we present a machine-learning framework to identify robust drug biomarkers by taking advantage of network-based analyses using pharmacogenomic data derived from three-dimensional organoid culture models. The  ...[more]

Similar Datasets

| S-EPMC7994645 | biostudies-literature
| S-EPMC7229843 | biostudies-literature
2021-02-22 | PXD019591 | Pride
| S-EPMC8467693 | biostudies-literature
| S-EPMC6382101 | biostudies-literature
| S-EPMC10480417 | biostudies-literature
| S-EPMC9739988 | biostudies-literature
| S-EPMC10803083 | biostudies-literature
| S-EPMC10081888 | biostudies-literature
| S-EPMC5851466 | biostudies-literature